Stabilizing the Tripartite Synaptic Complex Following TBI
TBI 后稳定三方突触复合体
基本信息
- 批准号:10581933
- 负责人:
- 金额:$ 56.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAgingAgonistAlzheimer&aposs DiseaseAmino Acid TransporterAmino AcidsAstrocytesAttentionAutopsyBehaviorBrainBrain InjuriesCellsCellular StructuresCognitionCognitiveComplementComplexConsciousDementiaDendritic SpinesElectrophysiology (science)EventFunctional disorderGene TargetingGeneticGenetic TechniquesGlycineHumanHuntington DiseaseImaging TechniquesImpaired cognitionInjuryInterventionLinkMediatingMediatorMicrodialysisMicrogliaModelingMusN-Methyl-D-Aspartate ReceptorsNeurodegenerative DisordersNeurogliaNeuronsNuclear RNAParkinson DiseasePathologicPathologyPatientsPhasePlayProcessResearch PersonnelRodentRoleSerineSourceSynapsesSynaptic TransmissionSynaptic plasticityTissuesTranslatingTraumatic Brain InjuryTraumatic injuryUnited States National Institutes of Healthbehavior measurementbrain cellbrain circuitrycentral nervous system injurycognitive functionexperimental studyextracellularhigh resolution imaginghuman modelhuman tissuein vivoinjuredinterdisciplinary approachlaser capture microdissectionmouse modelneuralneurotransmissionnovelnovel therapeuticspharmacologicpreservationresponsetranscriptome sequencingtranscriptomicstranslational potential
项目摘要
Summary:
Human consciousness and cognitive function are governed by a complex brain circuitry made up of neural
connections regulated by an integrated multicellular network. Glial make up 90% of all cells in the brain and play
dynamic and active roles in neuronal signaling, where astrocytes and microglia regulate synaptic transmission
and plasticity. In the past decade, increasing evidence suggests that the principal co-agonist for N-methyl-D-
Aspartate receptors (NMDARs) is the D-amino acid, D-serine, rather than glycine; however, few studies have
examined its role in CNS pathologies. To address this gap, we have recently identified a novel mechanism of
synaptic damage, where glia within the tripartite synapse uniquely synthesize and release D-serine following the
onset of pathological events. We hypothesize that microglia are a key source of pathological D-serine that
hyperactivates extrasynaptic NMDAR subunits to initiate synaptic damage as a result of microglia targeting and
pruning of dendritic spines. Our proposed experiments will examine (1) the mechanisms of D-serine release from
microglia; (2) the mechanisms of synaptic damage and microglia targeting & pruning; (3) transcriptomic analysis
of brain injury in both murine and human models. We will achieve this by employing both genetic and
pharmacological approaches to dissect the mechanism of microglial action within the complexity of brain injury
using state-of-the-art transcriptomic, imaging, and genetic techniques. Our studies will result in a better
understanding of the mechanisms that regulate synaptic damage and dysfunction, but also will start to define
novel therapeutics for patient interventions.
总结:
人类的意识和认知功能由一个复杂的大脑回路控制,
连接由一个综合的多细胞网络调节。神经胶质细胞占大脑所有细胞的90%,
在神经元信号传导中的动态和积极作用,其中星形胶质细胞和小胶质细胞调节突触传递
和可塑性。在过去的十年中,越来越多的证据表明,N-甲基-D-
天冬氨酸受体(NMDAR)是D-氨基酸,D-丝氨酸,而不是甘氨酸;然而,很少有研究表明,
研究了其在CNS病理学中的作用。为了解决这一差距,我们最近发现了一种新的机制,
突触损伤,其中三重突触内的胶质细胞独特地合成并释放D-丝氨酸,
病理事件的发生。我们假设小胶质细胞是病理性D-丝氨酸的关键来源,
超活化突触外NMDAR亚单位以引发作为小胶质细胞靶向的结果的突触损伤,
修剪树突棘。我们提出的实验将研究(1)D-丝氨酸释放的机制,
(2)突触损伤机制和小胶质细胞靶向修剪机制;(3)转录组学分析
在小鼠和人类模型中的脑损伤。我们将通过使用遗传和
在复杂脑损伤中剖析小胶质细胞作用机制的药理学方法
使用最先进的转录组成像和遗传技术我们的研究将使我们的国家
了解调节突触损伤和功能障碍的机制,也将开始定义
用于患者干预的新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Jon Liebl其他文献
Daniel Jon Liebl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Jon Liebl', 18)}}的其他基金
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 56.64万 - 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10056316 - 财政年份:2017
- 资助金额:
$ 56.64万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
7106557 - 财政年份:2005
- 资助金额:
$ 56.64万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8105912 - 财政年份:2005
- 资助金额:
$ 56.64万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
6966621 - 财政年份:2005
- 资助金额:
$ 56.64万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8415579 - 财政年份:2005
- 资助金额:
$ 56.64万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8215756 - 财政年份:2005
- 资助金额:
$ 56.64万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8792874 - 财政年份:2005
- 资助金额:
$ 56.64万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
7597062 - 财政年份:2005
- 资助金额:
$ 56.64万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8606255 - 财政年份:2005
- 资助金额:
$ 56.64万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 56.64万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 56.64万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 56.64万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 56.64万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 56.64万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 56.64万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 56.64万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 56.64万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 56.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 56.64万 - 项目类别:
Standard Grant














{{item.name}}会员




